期刊文献+

Vasostatin基因对胰腺癌内皮细胞迁移的影响 被引量:1

Inhibitory effect of vasostatin on migration of pancreatic cancer endothelial cells.
原文传递
导出
摘要 目的观察Vasostatin基因表达对胰腺癌内皮细胞迁移能力的影响。方法应用不同浓度的载有Vasostatin基因的腺病毒(Ad—vasostatin)感染胰腺癌内皮细胞,以Ad—lacZ感染及磷酸盐缓冲液(PBS)作为对照组。应用损伤修复、Transwell小室、小管形成3种不同方法观察胰腺癌内皮细胞迁移能力的变化及其与感染病毒的量效关系。结果培养48h后,PBS组与Ad—lacZ组的划痕损伤区域几乎完全恢复;而Ad-vasostatin组的划痕损伤区域无明显恢复。以MOI1、2、5感染细胞,Ad.1acZ组的迁移率分别为(84.7±2.6)%、(80.7±1.7)%和(81.3±4.0)%;Ad—vasostatin组为(77.7±2.1)%、(67.3±2.1)%和(38.8±2.1)%,Ad—vasostatin呈剂量依赖性抑制细胞迁移率,MOI:5时的细胞迁移率大幅度降低(F=180.88,P〈0.05)。以MOI1、5、10感染时,Ad-lacZ组的小管形成数分别为(118±6)、(120±6)、(82±5)个;Ad—vasostatin组为(65±4)、(21±4)、(4±1)个,Ad.vasostatin呈剂量依赖性抑制胰腺癌内皮细胞的小管形成,在MOI=10时已很难形成管状结构(F=300.85,P〈0.05)。结论Vasostatin基因能显著抑制胰腺癌内皮细胞的体外迁移能力,且呈剂量依赖性。 Objective To investigate the effect of vasostatin on the migration of pancreatic cancer endothelial cells. Methods Ad-vasostatin with different concentrations of vasostatin was used to transfect pancreatic cancer endothelial ceils. Ad-LacZ transfection and PBS was used as control. The effect of vasostatin gene mediated by adenovirus on the migration of pancreatic cancer endothelial cells was measured by wound- healing assay, transwell migration assay, and tube formation assay. Results The scratched lines in PBS group and Ad-LacZ group were almost healed 48 hours later, while the lines in Ad-vasostatin group were rarely healed. At the MOI of 1,2, 5, the migration rate of Ad-Laz group was (84.7± 2.6) %, (80.7± 1.7) % and (81.3±4.0)%, while the corresponding values were (77.7 ±2.1)%, (67.3 ±2.1)% and (38.8 ±2.1 )% in Ad-vasostatin group. Transwell migration assay indicated that the number of migrated cells in Ad- vasostatin group was inhibited in a dose-dependant manner, at the MOI of 5, the migration became significantly decreased (F = 180.88, P 〈 0. 05). At the MOI of 1, 5, 10, the number of tubes in Ad-LacZ group was 118 ±6, 120 ±6 and 82±5, while the corresponding values were 65 -±4, 21 ±4 and 4 ± 1 in Ad-vasostatin group. The number of tubes of pancreatic cancer endolhelial cells was inhibited by Ad-vasostatin in a dose-dependant manner, at the MOI of 10, it was difficult to form tile tubes (F =300.85, P 〈0.05). Conclusions The vasostatin gene mediated by adenovirus has a significanl inhibitory effect on the migration of pancreatic cancer endothelial cells in vitro in a dose-dependent manner.
出处 《中华胰腺病杂志》 CAS 2012年第1期16-18,共3页 Chinese Journal of Pancreatology
基金 国家自然科学基金(81072006) 上海市自然科学基金(07ZR14063) 国家留学基金(2009831457) 上海交通大学医学院“新百人计划”
关键词 胰腺肿瘤 细胞运动 内皮细胞 血管生成抑制剂 Pancreatic neoplasms Cell movement Endothelial cells Angiogenesis inhibitors
  • 相关文献

参考文献2

二级参考文献20

  • 1李雷,袁耀宗,章永平,乔敏敏,卢健.Vasostatin基因重组腺病毒载体的构建及其对胰腺癌生长的抑制作用[J].肿瘤,2004,24(6):538-541. 被引量:4
  • 2李雷,袁耀宗,章永平,乔敏敏,卢健.Vasostatin基因对胰腺癌血管生成的抑制作用[J].中华消化杂志,2005,25(10):590-593. 被引量:4
  • 3Pike SE,Yao L,Jones KD,et al.Vasostatin,a calreticulin fragment,inhibits angiogenesis and suppresses tumor growth.J Exp Med,1998,188:2349-2356.
  • 4Matsubara K,Matsumoto H,Mizushina Y,et al.Inhibitory effect of pyridoxal 5′-phosphate on endothelial cell proliferation,replicative DNA polymerase and DNA topoisomerase.Int J Mol Med,2003,12:51-55.
  • 5Folkman J.Fundamental concepts of the angiogenic process.Curr Mol Med,2003,3:643-651.
  • 6Francis PJ,Stout JT.Gene therapy and control of angiogenesis.Ophthalmol Clin North Am,2003,16:575-582.
  • 7Xiao F,Wei Y,Yang L,et al.A gene therapy for cancer based on the angiogenesis inhibitor,vasostatin.Gene Ther,2002,9:1207-1213.
  • 8Taraboletti G,Giavazzi R.Modelling approaches for angio-genesis.Eur J Cancer,2004,40:881-889.
  • 9Bussolati B, Deambrosis I, Russo S, et al. Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J, 2003, 17 (9): 1159-1161.
  • 10Hida K, Hida Y, Amin DN, et al. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res, 2004, 64 (22): 8249-8255.

共引文献1

同被引文献14

  • 1Pike SE. Yao L, Jones K D, et al . Vasoslatin , a calreticulin frag- merit, inhibits angiogenesis and suppresses tumor growth [ J ]. J Exp Med, 1998,188 ( 12 ) :2349-2356.
  • 2Browning DJ ,Roberg MH. Vitreous. hemorrhage complicating la- ser-induced chorioretinal anastomosis tbr central vein ocelusinn [J]. Am J Ophthalmol,1996,122(4) :588-658.
  • 3Ohno-Matsui K, Morila 1 , Tombrau-Tink .I , el al. Novel mecha- nism for age-related macular degeneration : an equilibrium shill between the angiogenesis factors VEGF and PEDF [ J ]. J Cell Physiol,2001 , 189(1):323-333.
  • 4Lambert HM. The management of subfocveal choroidal neovasculari- zation membranes hemorrhage[ J]. Semin Ophthalmol , 2000, 15 ( 1 ) :92-99.
  • 5Shu Q, Li W,Li H , et al . Vasoslatin inhibits VEGF-induced en- dothelial cell proliferation, tube formation and induces cell apopto- sis under oxygen deprivation[ J ]. lwt J Mol Sci. ,2014 , 15 ( 4 ) : 6019-6030.
  • 6Ramella R, Bocro O, Alloatti G,et al . Vasostatinl activates eNOS in endothelial cells through a proteoglycan-dependent mechanism [J]. J Cell Biochem, 2010,110 (1):70-79.
  • 7Dondossola E,Gasparri A, Bachi A, et al . Role of vasostatin-I C- terminal region in fibroblast cell adhesion . Cellular Molecular Life Sciences ,2010 ,67 ( 12 ) :2107-2018.
  • 8Peng XC,Wang M,Chen XX, et al . Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carci- noma cells [J]. Mol Cell Biochem, 2014 ,395(1-2) :265-272.
  • 9Cichofi T, Jarosz M, Smolarczyk R, et al . Vasostatin increases oxy- genation of B16-F10 melanoma tumors and raises therapeutic effi- cacy of cyclophosphamide. Acta Biochim Pol , 2012,59 ( 3 ) : 377-381.
  • 10Ayaz E,Nergiz Y,Tunik S, et al . The comparison of endogenous angiogenesis inhibitors in normotensive and preeclamptic placen- tas: an immunohistochemieal study [ J]. Hypertens Pregnancy , 2014 ,33(1) :61-71.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部